“The progression of myopia in school age children: data from the Columbia Medical Plan.”, Ophthalmic Epidemiol, vol. 3, no. 1, pp. 13-21, 1996.
, “The progression of myopia in school-age children: data from the Columbia Medical Plan,”, Ophthal Epidemiol, vol. 3, pp. 13-21, 1996.
, “A randomized trial (ISS 901) of switching to didanosine versus continued zidovudine after the diagnosis of AIDS,”, J Acquir Immune Defic Syndr Hum Retrovirol, vol. 12, pp. 462-9, 1996.
, “A randomized trial (ISS 901) of switching to didanosine versus continued zidovudine after the diagnosis of AIDS.”, J Acquir Immune Defic Syndr Hum Retrovirol, vol. 12, no. 5, pp. 462-9, 1996.
, “Realistic power simulations compare point- and area-based disease cluster tests.”, Stat Med, vol. 15, no. 7-9, pp. 783-806, 1996.
, “Realistic power simulations compare point- and area-based disease cluster tests,”, Stat Med, vol. 15, pp. 783-806, 1996.
, , “Safety and immunogenicity of a candidate HIV-1 vaccine in healthy adults: recombinant glycoprotein (rgp) 120,”, Ann Intern Med, vol. 125, p. 270, 1996.
, “Safety and immunogenicity of a candidate HIV-1 vaccine in healthy adults: recombinant glycoprotein (rgp) 120. A randomized, double-blind trial. NIAID AIDS Vaccine Evaluation Group.”, Ann Intern Med, vol. 125, no. 4, pp. 270-9, 1996.
, “Safety and immunogenicity of env 2-3, a human immunodeficiency virus type 1 candidate vaccine, in combination with a novel adjuvant, MTP-PE/MF59,”, AIDS Res Hum Retroviruses, vol. 12, pp. 683-93, 1996.
, , , “Trial of calcium for preeclampsia prevention (CPEP): rationale, design and methods,”, Control Clin Trials, vol. 17, pp. 442-69, 1996.
, “Trial of Calcium for Preeclampsia Prevention (CPEP): rationale, design, and methods.”, Control Clin Trials, vol. 17, no. 5, pp. 442-69, 1996.
, “Vinorelbine Tartrate [in the treatment of breast cancer],”, American Hospital Formulary Service Drug Information, pp. 802-04, 1996.
, ,
“Antibody to human immunodeficiency virus type 1 (HIV) gp160 in mucosal specimens of asymtomatic HIV-1-infected volunteers parenterally immunized with an experimental recombinant HIV-1 111B gp 160 vaccine,”, Clin Diag Lab Immunol, vol. 4, pp. 302-8, 1997.
, , “Cigarette smoking and the risk of development of lens opacities.”, Arch Ophthalmol, vol. 115, pp. 1113-18, 1997.
, “Cigarette smoking and the risk of development of lens opacities. The Framingham studies.”, Arch Ophthalmol, vol. 115, no. 9, pp. 1113-8, 1997.
, “Clinical Trials Referral Resource. Clinical trials in AIDS related malignancies.”, Oncology (Williston Park), vol. 11, no. 3, pp. 337-8, 341, 1997.
, “Clinical trials referral resource. Clinical trials in AIDS-related malignancies.”, Oncology, vol. 11, pp. 337-41, 1997.
, “Clinical Trials Referral Resource. Clinical trials in bladder and urothelial cancers.”, Oncology (Williston Park), vol. 11, no. 9, p. 1348, 1351, 1997.
, “Clinical trials referral resource. Clinical trials in elderly patients.”, Oncology, vol. 11, pp. 838-44, 1997.
, “Clinical trials referral resource. Clinical trials in lung cancer.”, Oncology (Williston Park), vol. 11, no. 11, p. 1686, 1688, 1691, 1694, 1997.
,